Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3597]

Biomarkers may help identify patients at increased risk of neurotoxicity from CD19 CAR T-cell therapy

Biomarkers may help identify patients at increased risk of neurotoxicity from CD19 CAR T-cell therapy

Anti-RAS antibodies show poor reliability in recognising RAS proteins

Anti-RAS antibodies show poor reliability in recognising RAS proteins

Good-guy bacteria may help cancer immunotherapies do their job

Good-guy bacteria may help cancer immunotherapies do their job

New key regulator of acquisition of immune tolerance to tumour cells in cancer patients

New key regulator of acquisition of immune tolerance to tumour cells in cancer patients

Trastuzumab treatment need not delay breast reconstruction following mastectomy

Trastuzumab treatment need not delay breast reconstruction following mastectomy

New key regulator of acquisition of immune tolerance to tumour cells in cancer patients

New key regulator of acquisition of immune tolerance to tumour cells in cancer patients

CAR T cell breakthrough brings hope and challenges

CAR T cell breakthrough brings hope and challenges

By decoding how HPV causes cancer, researchers find a new potential treatment strategy

By decoding how HPV causes cancer, researchers find a new potential treatment strategy

Researchers look to protect 'self-reactive' immune cells so they can fight melanoma

Researchers look to protect 'self-reactive' immune cells so they can fight melanoma

Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapy

Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapy

More from ecancer